Duloxetine in obese binge eater outpatients: Preliminary results from a 12-week open trial

Human Psychopharmacology

Volumn 24, Issue 6, 2009, Pages 483-488

  Leombruni, Paolo ^a   Lavagnino, Luca ^a   Gastaldi, Filippo ^a   Vasile, Alessia ^a   Fassiono, Secondo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Binge eaters; Binge eating disorder; Duloxetine; Obesity; SNRI

Indexed keywords

DULOXETINE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BINGE EATING DISORDER; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; EATING HABIT; EVENING DOSAGE; FEMALE; HUMAN; IMPULSIVENESS; INSOMNIA; MALE; MORNING DOSAGE; NAUSEA; OBESITY; OUTPATIENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; SIDE EFFECT;

ADULT; BULIMIA; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SEROTONIN UPTAKE INHIBITORS; THIOPHENES;

EID: 70349545821     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1040     Document Type: Article

References (40)

1. Adams KF, Schatzkin A, Harris TB, et al. 2006. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355: 763-778.
2. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders, (4th edn) Text Revision. American Psychiatric Press: Washington, DC.
3. Appolinario JC, Bacaltchuck J, Sichieri R, Claudino AM, Godoy-Matos A, Morgan C. 2003. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Arch Gen Psychiatry 60: 1109-1116.
4. Appolinario JC, McElroy SL. 2004. Pharmacological approaches in the treatment of binge eating disorder. Curr Drug Targets 5: 301-307.
5. Beck AT, Steer RA. 1987. Beck Depression Manual. Psychological Corporation: New York.
6. Bernardi S, Pallanti S. 2008. Successful duloxetine treatment of a binge eating disorder: a case report. J Psychopharmacol 00: 1-4 (epub ahead of print).
7. Bulik CM, Brownley KA, Shapiro JR. 2007. Diagnosis and management of binge eating disorder. World Psychiatry 6: 142-148.
8. Davidson J, Allgulander C, Pollack MH, et al. 2008. Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies. Hum Psychopharmacol 23: 519-526.
9. Dell'osso B, Mundo E, Marazziti D, Altamura AC. 2008. Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive compulsive disorder: a case series. J Psychopharmacol 22: 210-213.
10. Devlin MJ, Goldfein JA, Carino JS, Wolk SL. 2001. Open treatment of overweight binge eaters with phentermine and fluoxetine as an adjunct to cognitive-behavioral therapy. Int J Eat Disord 28: 325-332.
11. Fairburn CG, Cooper Z, Shafran R. 2003. Cognitive behaviour therapy for eating disorders: a "transdiagnostic" theory and treatment. Behav Res Therapy 41: 509-528.
12. Fava GA, Tomba E, Grandi S. 2007. The road to recovery from depression-don't drive today with yesterday's map. Psychoter Psychosom 76: 260-265.
13. Fichter MM, Quadflieg N, Hedlund S. 2008. Long-term course of binge eating disorder and bulimia nervosa: relevance for nosology and diagnostic criteria. Int J Eat Disorder 41: 577-586.
14. Fontenelle LF, Vl'tor Mendlowicz M, de Menezes GB, et al. 2003. Psychiatric comorbidity in a Brazilian sample of patients with binge-eating disorder. Psychiatry Res 119: 189-194.
15. Friederich HC, Schild S, Wild B, et al. 2007. Treatment outcome in people with subthreshold compared with full-syndrome binge eating disorder. Obesity 15: 283-287.
16. Furlanetto LM, Mendlowicz MV, Bueno JL. 2005. The validity of the Beck Depression Inventory-short form as a screening and diagnostic instrument for moderate and severe depression in medical inpatients. J Affective Disord 86: 87-91.
17. Garner DM, Olmsted MP, Polivy J. 1983. Development and validation of a multidimensional eating disorder inventory for anorexia nervosa and bulimia. Int J Eat Disord 2: 15-34.
18. Gormally J, Black S, Daston S, Rardin D. 1982. The assessment of binge eating severity among obese patients. Addict Behav 7: 47-59.
19. Grilo CM, Masheb RM, Wilson GT. 2005. Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison. Biol Psychiatry 57: 301-309.
20. Groth-Marnat G. 1990. The Handbook of Psychological Assessment, 2nd edn, John Wiley & Sons: New York.
21. Guerdjikova AI, McElroy SL. 2009. Binge eating disorders pharmacotherapy clinical trials-who is left out? Eur Eat Disorders Rev 17: 101-108.
22. Gupta S, Nihalani N, Masand P. 2007. Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders. Annals of Clinical Psychiatry 19: 125-132.
23. Hazen E, Fava M. 2006. Successful treatment with duloxetine in a case of treatment refractory bulimia nervosa: a case report. J Psychopharmacol 20: 723-724.
24. Holt RI. 2005. Obesity - an epidemic of the twenty-first century: an update for psychiatrists. J Psychopharmacol 19 (6 Suppl): 6-15.
25. Jacob-Piliski MJ, Wilfley DE, Crow SJ, et al. 2007. Placebo response in binge eating disorder. Int J Eat Disord 40: 204-211.
26. Ji D, Gilpin NW, Richardson HN, Rivier CL, Koob GF. 2008. Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats. Behav Pharmacol 19: 1-12.
27. Laederach-Hofmann K, Graf C, Horber F, Lippuner K, Lederer S, Michel R. 1999. Imipramine and diet counseling with psychological support in the treatment of obese binge eaters: a randomized placebo-controlled double-blind study. Int J Eat Disord 26: 231-244.
28. Latner JD, Clyne C. 2008. The diagnostic validity of the criteria for binge eating disorder. Int J Eat Disord 41: 1-14.
29. Leombruni P, Pierò A, Brustolin A, et al. 2006. A 12 to 24 weeks pilot study of sertraline treatment in obese women binge eaters. Hum Psychopharmacol Clin Exp 21: 181-188.
30. Leombruni P, Pierò A, Lavagnino L, Brustolin A, Campisi S, Fassino S. 2008. A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder. Prog Neuropsychopharmacol Biol Psychiatry 32: 1599-1605.
31. Malhotra S, King KH, Welge JA, Brusman-Lovins L, McElroy SL. 2002. Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients. J Clin Psychiatry 63: 802-806.
32. McElroy SL, Arnold LM, Shapira NA, Welge JA, Nelson EP, Keck PE. 2003. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry 160: 255-261.
33. McGee DL. Diverse Populations Collaboration. 2005. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol 15: 87-97.
34. National Institute for Clinical Excellence. 2004. Eating Disorders-Core Interventions in the Treatment and Management of Anorexia Nervosa, Bulimia Nervosa, and Related Eating Disorders. National Institute for Clinical Excellence: London.
35. Perahia DG, Quail D, Desaiah D, Corruble E, Fava M. 2008. Switching to duloxetine from selective serotonin reuptake inhibitor antidepressants: a multicenter trial comparing 2 switching techniques. J Clin Psychiatry 69: 95-105.
36. Perroud N, Relecom C, Huguelet P. 2008. Successful treatment of nicotine withdrawal with duloxetine: a case report. J Clin Psychopharmacol 28: 102-104.
37. Reas DL, Grilo C. 2008. Review and meta-analysis of pharmacotherapy for binge-eating disorder. Obesity 16: 2024-2038.
38. Ricca V, Mannucci E, Mezzani B, et al. 2001. Fluoxetine and fluvoxamine combined with individual cognitive behaviour therapy in binge eating disorder: a one-year follow-up study. Psychother Psychosom 70: 298-306.
39. SPSS 12.1. SPSS Inc. Chicago, IL, USA.
40. Zhu AJ, Walsh BT. 2002. Pharmacologic treatment of eating disorders. Can J Psychiatry 47: 227-234.